Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/2003
11/06/2003CA2483253A1 Use of compounds having ccr antagonism
11/06/2003CA2483155A1 Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them
11/06/2003CA2483075A1 Triaryl-oxy-aryl-spiro-pyrimidine-2, 4, 6-trione metalloproteinase inhibitors
11/06/2003CA2483005A1 Treatment of metabolic syndrome
11/06/2003CA2482936A1 Capsule preparation
11/06/2003CA2482455A1 1,2,3,4,7,8-hexahydro-6h-[1,4]diazepino[6,7,1-ij]quinoline derivatives as antipsychotic and antiobesity agents
11/06/2003CA2482432A1 Method of preparing amine stereoisomers
11/06/2003CA2481324A1 [1,4]diazocino [7,8,1-hi]indole derivatives as antipsychotic and antiobesity agents
11/06/2003CA2480497A1 Substituted pyrazine derivatives
11/06/2003CA2480268A1 Chromium compositions and methods for using the same for inhibiting drug-induced insulin resistance
11/06/2003CA2480092A1 N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
11/05/2003EP1359215A1 Soya cell strains with high isoflavone content
11/05/2003EP1359159A2 Analogues of GLP-1
11/05/2003EP1358881A1 Use of biogenic estriol diester prodrugs for the treatment of autoimmune diseases
11/05/2003EP1358879A1 Antilipemic agents
11/05/2003EP1358354A1 Method for identifying compounds modulating reverse cholesterol transport
11/05/2003EP1358353A2 Identification of genetic determinants of polymorphic cyp3a5 expression
11/05/2003EP1358329A2 Lipid-associated molecules
11/05/2003EP1358328A2 Regulation of human serotonin-like g protein-coupled recepter
11/05/2003EP1358327A2 Proteins and nucleic acids encoding same
11/05/2003EP1358325A2 Protein modification and maintenance molecules
11/05/2003EP1358323A2 Regulators of apoptosis
11/05/2003EP1358209A2 Crystallization of igf-1
11/05/2003EP1358186A1 Laulimalide derivatives
11/05/2003EP1358178A2 Sulfonamide lactam inhibitors of factor xa
11/05/2003EP1358172A2 Amino ceramide-like compounds and therapeutic methods of use
11/05/2003EP1358171A2 Novel urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use
11/05/2003EP1358163A1 Melanocortin receptor agonists
11/05/2003EP1358162A1 Dihydroindole and tetrahydroquinoline derivatives
11/05/2003EP1358161A2 N-pyridyl carboxamide derivatives and pharmaceutical compositions containing them
11/05/2003EP1358157A1 Carbazole derivatives and their use as neuropeptide y5 receptor ligands
11/05/2003EP1358153A1 Ophthalmic compositions for treating ocular hypertension
11/05/2003EP1357977A2 Chromium containing compositions for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity and reduction of hyperglycemia and hypercholesteremia
11/05/2003EP1357973A2 Gssp4 polynucleotides and polypeptides and uses thereof
11/05/2003EP1357925A2 Compositions containing an active fraction isolated from hedyotis diffusae and methods of use
11/05/2003EP1357914A2 Treatment of ppar mediated diseases
11/05/2003EP1357908A2 Acyl sulfamides for treatment of obesity, diabetes and lipid disorders
11/05/2003EP1357903A2 STABILIZED FORMULATIONS OF 6-HYDROXY-3-(4- 2-(PIPERIDIN-1-YL) ETHOXY]PHENOXY)-2-(4-METHOXYPHENYL) BENZO b]THIOPHENE AND SALTS THEREOF
11/05/2003EP1357900A2 Process for production of nanoparticles and microparticles by spray freezing into liquid
11/05/2003EP1357855A2 Ophthalmic compositions for treating ocular hypertension
11/05/2003EP1140113B1 Use of bisphosphonates for the prevention and treatment of infectious processes
11/05/2003EP1107973B1 NOVEL THIENO[2,3-d]PYRIMIDINEDIONES, PROCESS FOR THEIR PREPARATION AND USE THEREOF IN THERAPY
11/05/2003EP1054857B1 Biaryl-acetic acid derivatives and their use as cox-2 inhibitors
11/05/2003EP1044007B1 Mannose for combating protein loss enteropathy
11/05/2003EP0975617B1 Inhibitors of cholesterol esterase
11/05/2003EP0839039B1 Paroxetine controlled release compositions
11/05/2003EP0489058B1 Cystic fibrosis gene
11/05/2003CN1454256A The high bone mass gene of 11q13.3
11/05/2003CN1454214A Modified peptides with increased potency
11/05/2003CN1454213A Variants of allergenic proteins of the Group2 of dermatophagoides
11/05/2003CN1454104A Needle for intradermal delivery of substances having penetration limiting means
11/05/2003CN1454089A Diabetes remedies
11/05/2003CN1454086A High affinity small molecule C5A receptor modulators
11/05/2003CN1453265A Aromatic amino acid derivative and its prepn process and medicinal use
11/05/2003CN1453043A Microbiological cellulose injury dressing for treating chronic injury
11/05/2003CN1453024A Compound Chinese medicine prepn containing white mulberry bark and bitter buckwheat with hypoglycemic effect and its prepn process
11/05/2003CN1452990A Diabetes treating medicine
11/05/2003CN1452973A Orally taken antioxidant and antilipemic medicine
11/05/2003CN1452972A Plant extractive composition containing ginkgetin and its use
11/05/2003CN1452971A Composition of gensenoside Rg1 and ferulic acid for preventing and treating cardiac and cerebral vascular diseases and diabetes and its application
11/05/2003CN1452961A New use of theaflavin
11/05/2003CN1126557C Medicine for treating diabetes and its preparing process
11/05/2003CN1126541C Compound amino acid composition
11/05/2003CN1126457C Rhodiola tea
11/04/2003US6642411 Compounds and compositions for delivering active agents
11/04/2003US6642389 Oxazole derivatives
11/04/2003US6642381 Pyrimido[5,4-e][1,2,4]triazine-5,7-diamine compounds as protein tyrosine phosphatase inhibitors
11/04/2003US6642256 Brain disorders, psychological disorders, antiischemic agents, central nervous system disorders
11/04/2003US6642251 Antitumor, 2-indolinone derivatives
11/04/2003US6642250 1,8-naphthyridin-2(1H)-one derivatives
11/04/2003US6642247 Treting anxiety, stress, depression, trauma, Alzheimer's mediated memory loss, epilepsy, arterial blood pressure disorders, obesity, acute pain, chronic pain, Na+ excretion, control of water balance, and symptoms associated with drug
11/04/2003US6642239 Dipeptide nitrile cathepsin K inhibitors
11/04/2003US6642235 Administering a therapeutically effective amount of a formulation comprising compound having a pharmacological selectivity of serotonin (Ki)/norepinephrine (Ki) of 5000; for selectively inhibiting reuptake of norepinephrine
11/04/2003US6642232 3-[4-Substituted heterocyclyl)-pyrrol-2-ylmethylidene]-2- indolinone derivatives as kinase inhibitors
11/04/2003US6642227 Such as 2-methylsulfanyl-5-(2-phenylamino-pyrimidin-4-yl)-4-p-tolyl-thiophene-3 -carbonitrile; antiproliferative agents; stents
11/04/2003US6642223 Benzoheterocyclic derivatives
11/04/2003US6642216 Osteoporosis, periodontal diseases
11/04/2003US6642212 Health supplement comprising naturally occurring phytoestrogen selected from any two or more of genistein, daidzein and/or their glycosides
11/04/2003US6642008 Assays and therapies for latent viral infection
11/04/2003US6641841 N-(trans-4-isopropylcyclohexanecarbonyl)-D-phenylalanine and low sustituted hydroxypropylcellulose; controlling the blood sugar levels of diabetics.
11/04/2003US6641808 Composition for treatment of obesity
11/04/2003CA2084677C Apo ai polypeptides, antibodies, and immunoassays
11/04/2003CA2040555C Cloned glutamic acid decarboxylase
10/2003
10/31/2003CA2444598A1 Compositions useful as inhibitors of gsk-3
10/30/2003WO2003089638A1 Nucleic acid molecule encoding a variant ddah 1 protein and uses thereof
10/30/2003WO2003089573A2 Methods of identifying compounds that modulate a dna repair pathway and/or retroviral infectivity, the compounds, and uses thereof
10/30/2003WO2003089438A1 Labeled oxazinocarbazoles as diagnostic agents
10/30/2003WO2003089434A2 IMIDAZO[1,2-a]PYRAZIN-8-YLAMINES METHOD OF MAKING AND METHOD OF USE THEREOF
10/30/2003WO2003089419A1 New 2-substituted -1,3-thiazole compounds
10/30/2003WO2003089418A1 Indane acetic acid derivatives and their use as pharmaceutical agents
10/30/2003WO2003089410A1 Phenylalanine derivative
10/30/2003WO2003088984A1 Compositions and methods for augmenting kidney function
10/30/2003WO2003088977A1 (20S)-1α-HYDROXY-2α-METHYL AND 2β-METHYL-19-NOR-VITAMIN D3 AND THEIR USES
10/30/2003WO2003088976A1 Method for treating and preventing hyperparathyroidism
10/30/2003WO2003088974A1 Pharmaceutical composition
10/30/2003WO2003088972A1 Novel compounds
10/30/2003WO2003088967A1 (1-4-piperidinyl) benzimidazole derivatives useful as histamine h3 antagonists
10/30/2003WO2003088962A1 Combination therapy using a ppar alpha/gamma agonist
10/30/2003WO2003088945A1 Aerosol containing a particulate active substance
10/30/2003WO2003088908A2 Heterocyclo inhibitors of potassium channel function
1 ... 859 860 861 862 863 864 865 866 867 868 869 870 871 872 873 874 875 876 877 878 879 ... 1298